Pharmacogenomic Data Submissions to the FDA: Clinical Case Studies
- 1 July 2004
- journal article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 5 (5) , 519-524
- https://doi.org/10.1517/14622416.5.5.519
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Pharmacogenomic Data: FDA Voluntary and Required Submission GuidancePharmacogenomics, 2004
- Pharmacogenomics in Drug Development and Regulatory Decision-making: the Genomic Data Submission (GDS) ProposalPharmacogenomics, 2004
- Pharmacogenetics and Pharmacogenomics in Drug Development and Regulatory Decision Making: Report of the First FDA‐PWG‐PhRMA‐DruSafe WorkshopThe Journal of Clinical Pharmacology, 2003